Evidence map›Paper›PMID 39624781›Full record

ArticleBiomedical reports2025

Long COVID‑19 and pregnancy: A systematic review.

Vasiliki Epameinondas Georgakopoulou, Chrysoula Taskou, Demetrios A Spandidos, Antigoni Sarantaki

Abstract read
In one paragraph

Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vasiliki Epameinondas GeorgakopoulouDepartment of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Chrysoula TaskouDepartment of Midwifery, Faculty of Health and Caring Sciences, University of West Attica, 12243 Athens, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.
Antigoni SarantakiDepartment of Midwifery, Faculty of Health and Caring Sciences, University of West Attica, 12243 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of post-acute sequelae of SARS-CoV-2 infection, or Long coronavirus disease 2019 (COVID-19), on pregnant women remains a growing concern. The present systematic review synthesizes current evidence on the prevalence, risk factors and clinical outcomes of Long COVID-19 in pregnant women to improve understanding of its burden and implications for maternal health. A systematic search was conducted in PubMed, Scopus and Google Scholar for studies published between January 2020 and October 2024. Eligible studies included pregnant or postpartum women diagnosed with COVID-19 and followed for at least four weeks post-infection. Data extraction and quality assessment were performed using standardized tools, and the findings were narratively synthesized due to heterogeneity in study designs and outcome measures. A total of 13 studies encompassing 13,729 participants were included. The prevalence of Long COVID-19 varied widely, ranging from 9.3-93%. The most reported symptoms included fatigue, cognitive dysfunction, respiratory symptoms and psychological disturbances, with fatigue being the most prevalent. Severe acute COVID-19, obesity, pre-existing mental health conditions, and non-vaccination were identified as key risk factors for developing Long COVID-19. Several studies reported that women with Long COVID-19 were at a higher risk for adverse maternal and neonatal outcomes, such as preterm birth and increased need for neonatal intensive care. The severity of acute infection and the presence of comorbidities significantly influenced the risk and severity of Long COVID-19. Long COVID-19 is a prevalent condition among pregnant women, with significant variability in reported prevalence rates. It is associated with a range of symptoms that can impact maternal health and pregnancy outcomes. The findings highlight the need for targeted follow-up and management strategies in this population. Standardized definitions and longitudinal studies are essential to further elucidate the long-term impact of COVID-19 during pregnancy.

Indexed as

COVID-19long COVID-19maternal healthpost-acute sequelaepregnancy

Identifiers

PMID39624781
PMCPMC11609607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.